{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:22:56Z","timestamp":1785842576573,"version":"3.56.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,6,6]],"date-time":"2014-06-06T00:00:00Z","timestamp":1402012800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s00292-014-1908-0","type":"journal-article","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T19:01:29Z","timestamp":1401908489000},"page":"322-326","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Neue FIGO-Klassifikation des Ovarial-, Tuben und prim\u00e4ren Peritonealkarzinoms","New FIGO classification of ovarian, fallopian tube and primary peritoneal cancer"],"prefix":"10.1007","volume":"35","author":[{"given":"A.K.","family":"H\u00f6hn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Einenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Wittekind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.-C.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,6]]},"reference":[{"key":"1908_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","volume":"124","author":"Prat","year":"2014","unstructured":"Prat J, FIGO Committee on Gynecologic Oncology (2014) Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet 124:1\u20135","journal-title":"Int J Gynaecol Obstet"},{"key":"1908_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/AOG.0b013e3181917a0c","volume":"113","author":"Bakkum-Gamez","year":"2009","unstructured":"Bakkum-Gamez JN, Richardson DL, Seamon LG et al (2009) Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian cancer. Obstet Gynecol 113:11\u201317","journal-title":"Obstet Gynecol"},{"key":"1908_CR3","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/cncr.23390","volume":"112","author":"Chan","year":"2008","unstructured":"Chan JK, Tian C, Monk BJ et al (2008) Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Cancer 112:2202\u20132210","journal-title":"Cancer"},{"key":"1908_CR4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ygyno.2006.09.021","volume":"104","author":"Obermair","year":"2007","unstructured":"Obermair A, Fuller A, Lopez-Varela E et al (2007) A new prognostic model for FIGO stage 1 epithelial ovarian cancer. Gynecol Oncol 104:607\u2013611","journal-title":"Gynecol Oncol"},{"key":"1908_CR5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/gyno.1999.5349","volume":"73","author":"Kanazawa","year":"1999","unstructured":"Kanazawa K, Suzuki T, Tokashiki M (1999) The validity and significance of substage IIIC by node involvement in epithelial ovarian cancer: impact of nodal metastasis on patient survival. Gynecol Oncol 73:237\u2013241","journal-title":"Gynecol Oncol"},{"key":"1908_CR6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/jnci\/dji102","volume":"97","author":"Panici","year":"2005","unstructured":"Panici PB, Maggioni A, Hacker N et al (2005) Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst 97:560\u2013566","journal-title":"J Natl Cancer Inst"},{"key":"1908_CR7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ygyno.2006.08.047","volume":"103","author":"Cliby","year":"2006","unstructured":"Cliby WA, Aletti GD, Wilson TO, Podratz KC (2006) Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only? Gynecol Oncol 103:797\u2013801","journal-title":"Gynecol Oncol"},{"key":"1908_CR8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ygyno.2007.05.016","volume":"107","author":"Ferrandina","year":"2007","unstructured":"Ferrandina G, Scambia G, Legge F et al (2007) Ovarian cancer patients with \u201enode-positive-only\u201c stage IIIC disease have a more favorable outcome than Stage IIIA\/B. Gynecol Oncol 107:154\u2013156","journal-title":"Gynecol Oncol"},{"key":"1908_CR9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3802\/jgo.2008.19.4.223","volume":"19","author":"Baek","year":"2008","unstructured":"Baek SJ, Park JY, Kim DY et al (2008) Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer. J Gynecol Oncol 19:223\u2013228","journal-title":"J Gynecol Oncol"},{"key":"1908_CR10","first-page":"195","volume":"24","author":"Wuttke","year":"2013","unstructured":"Wuttke P (2013) Medikament\u00f6se Therapie des Ovarialkarzinoms. \u00c4rztebl Sachsen 24:195\u2013197","journal-title":"\u00c4rztebl Sachsen"},{"key":"1908_CR11","unstructured":"Cannistra SA, Gershenson DM, Recht A (2011) Ovarian cancer, fallopian tube carcinoma and peritoneal carcinoma. In: De Vita VT, Lawrence TS, Rosenberg SA (Hrsg) De Vita, Hellman and Rosenberg\u2019s cancer: principles and practice of oncology. Lippincott, Williams & Wilkins, Philadelphia, S\u00a01368\u20131391"},{"key":"1908_CR12","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrc3144","volume":"11","author":"Vaughan","year":"2011","unstructured":"Vaughan S, Coward JI, Bast RC Jr et al (2011) Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer 11:719\u2013725","journal-title":"Nat Rev Cancer"},{"key":"1908_CR13","doi-asserted-by":"crossref","unstructured":"Kuhn W (2013) Maligne Ovarialtumoren. In: Ulrich UA (Hrsg) Gyn\u00e4kologische Onkologie. De Gruyter, Berlin, S\u00a0149\u2013192","DOI":"10.1515\/9783110216264.149"},{"key":"1908_CR14","first-page":"335","volume":"117","author":"Horn","year":"1995","unstructured":"Horn LC, Fricke K, Krugmann J (1995) Histologic classification and morphologic prognostic factors in malignant ovarian tumors. Zentralbl Gynakol 117:335\u2013345","journal-title":"Zentralbl Gynakol"},{"key":"1908_CR15","unstructured":"AGO: S3-Leitlinie Ovarialkarzinom. http:\/\/www.ago-online.de\/fileadmin\/downloads\/leitlinien\/ovar\/S3-Ovarialkarzinom-OL-Langversion.pdf"},{"key":"1908_CR16","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.humpath.2009.04.017","volume":"40","author":"Gilks","year":"2009","unstructured":"Gilks CB, Prat J (2009) Ovarian carcinoma pathology and genetics: recent advances. Hum Pathol 40:1213\u20131223","journal-title":"Hum Pathol"},{"key":"1908_CR17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-8722-5-8","volume":"5","author":"Li","year":"2012","unstructured":"Li J, Fadare O, Xiang L et al (2012) Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis. J Hematol Oncol 5:8","journal-title":"J Hematol Oncol"},{"key":"1908_CR18","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","volume":"42","author":"Kurman","year":"2011","unstructured":"Kurman RJ, Shih IeM (2011) Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer \u2013 shifting the paradigm. Hum Pathol 42:918\u2013931","journal-title":"Hum Pathol"},{"key":"1908_CR19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ygyno.2012.04.029","volume":"126","author":"Diaz-Padilla","year":"2012","unstructured":"Diaz-Padilla I, Malpica AL, Minig L et al (2012) Ovarian low-grade serous carcinoma: a comprehensive update. Gynecol Oncol 126:279\u2013285","journal-title":"Gynecol Oncol"},{"key":"1908_CR20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/PGP.0b013e3181c042b6","volume":"29","author":"K\u00f6bel","year":"2010","unstructured":"K\u00f6bel M, Kalloger SE, Huntsman DG et al (2010) Differences in tumor type in low-stage versus high-stage ovarian carcinomas. Int J Gynecol Pathol 29:203\u2013211","journal-title":"Int J Gynecol Pathol"},{"key":"1908_CR21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/path.4134","volume":"229","author":"Ryland","year":"2013","unstructured":"Ryland GL, Hunter SM, Doyle MA et al (2013) RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary. J Pathol 229:469\u2013476","journal-title":"J Pathol"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-014-1908-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-014-1908-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-014-1908-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T04:13:25Z","timestamp":1565496805000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-014-1908-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,6]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["1908"],"URL":"https:\/\/doi.org\/10.1007\/s00292-014-1908-0","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,6]]}}}